Magnitude , Associated Factors, and Outcome of Neonatal Hyperglycemia among Neonates Admitted To NICU At TASH : Cross Sectional Study
| dc.contributor.advisor | Mekasha, Amha (Prof.) | |
| dc.contributor.author | Ayalew, Tsion | |
| dc.date.accessioned | 2026-01-30T11:39:45Z | |
| dc.date.available | 2026-01-30T11:39:45Z | |
| dc.date.issued | 2025-04-15 | |
| dc.description.abstract | Hyperglycemia in neonates is a common metabolic disorder among preterm and critically ill newborns, occurring in one-third of preterm and small-for-gestational-age (SGA) infants. Hyperglycemia is most common in extremely preterm infants during the first week of life, with prevalence rates between 20-88%; in very low birth weight (VLBW) infants, prevalence is 40-80%. Multiple clinical determinants contribute to increased risk, particularly preterm delivery, low birth weight, disease progression, bloodstream infections, hypoxic events, depressed APGAR results, surgical stress, and metabolic stressors. Acute consequences of neonatal hyperglycemia encompass fluid depletion, electrolyte imbalances, cerebral hemorrhage, and elevated mortality risk. Potential long-term sequelae involve neurodevelopmental impairments and vision-threatening retinopathy. Method: | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/7606 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | Neonatal Hyperglycemia among Neonates Admitted To NICU | |
| dc.title | Magnitude , Associated Factors, and Outcome of Neonatal Hyperglycemia among Neonates Admitted To NICU At TASH : Cross Sectional Study | |
| dc.type | Thesis |